Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo

Virology

Volumn 468, Issue , 2014, Pages 601-608

  Barrett, Bradley S ^a   Guo, Kejun ^a   Harper, Michael S ^a   Li, Sam X ^a   Heilman, Karl J ^a   Davidson, Nicholas O ^b   Santiago, Mario L ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

APOBEC1; APOBEC3; Deaminase; Friend retrovirus; HIV 1; Hypermutation; Innate immunity; Restriction factor

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; GENOMIC DNA; APOLIPOPROTEIN B MRNA EDITING ENZYME; CYTIDINE DEAMINASE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEAMINATION; ENZYME ACTIVITY; IN VIVO STUDY; MOLECULAR EVOLUTION; MOUSE; NONHUMAN; RETROVIRUS INFECTION; VIREMIA; VIRUS INHIBITION; VIRUS REPLICATION; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; EXPERIMENTAL LEUKEMIA; FRIEND MURINE LEUKEMIA VIRUS; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MUTATION; PHYSIOLOGY; VIROLOGY; VIRUS INFECTION; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

ANIMALS; CYTIDINE DEAMINASE; FRIEND MURINE LEUKEMIA VIRUS; GENE EXPRESSION REGULATION; LEUKEMIA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MUTATION; RETROVIRIDAE INFECTIONS; TUMOR VIRUS INFECTIONS; VIRAL LOAD; VIREMIA; VIRUS REPLICATION;

EID: 84908014562     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.09.006     Document Type: Article

References (77)

1. Abdel-Mohsen M., Deng X., Liegler T., Guatelli J.C., Salama M.S., Ghanem Hel D., Rauch A., Ledergerber B., Deeks S.G., Gunthard H.F., Wong J.K., Pillai S.K. Effects of alpha interferon treatment on intrinsic anti-HIV-1 immunity in vivo. J. Virol. 2014, 88:763-767.
2. Beale R.C., Petersen-Mahrt S.K., Watt I.N., Harris R.S., Rada C., Neuberger M.S. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. J. Mol. Biol. 2004, 337:585-596.
3. Bishop K.N., Holmes R.K., Sheehy A.M., Davidson N.O., Cho S.J., Malim M.H. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 2004, 14:1392-1396.
4. Bishop K.N., Holmes R.K., Sheehy A.M., Malim M.H. APOBEC-mediated editing of viral RNA. Science 2004, 305:645.
5. Bishop K.N., Verma M., Kim E.Y., Wolinsky S.M., Malim M.H. APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog. 2008, 4:e1000231.
6. Blanc V., Davidson N.O. APOBEC-1-mediated RNA editing. Wiley Interdiscip. Rev. Syst. Biol. Med. 2010, 2:594-602.
7. Blanc V., Park E., Schaefer S., Miller M., Lin Y., Kennedy S., Billing A.M., Ben Hamidane H., Graumann J., Mortazavi A., Nadeau J.H., Davidson N.O. Genome-wide identification and functional analysis of Apobec-1 mediated C-to-U RNA editing in mouse small intestine and liver. Genome Biol. 2014, 15:R79.
8. Blanc V., Xie Y., Luo J., Kennedy S., Davidson N.O. Intestine-specific expression of Apobec-1 rescues apolipoprotein B RNA editing and alters chylomicron production in Apobec1 -/- mice. J. Lipid Res. 2012, 53:2643-2655.
9. Brown M.S., Goldstein J.L. Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man. Science 1974, 185:61-63.
10. Chesebro B., Britt W., Evans L., Wehrly K., Nishio J., Cloyd M. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus. Virology 1983, 127:134-148.
11. Conticello S.G., Thomas C.J., Petersen-Mahrt S.K., Neuberger M.S. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol. Biol. Evol. 2005, 22:367-377.
12. Duggal N.K., Emerman M. Evolutionary conflicts between viruses and restriction factors shape immunity. Nat. Rev. Immunol. 2012, 12:687-695.
13. Edgar R.C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010, 26:2460-2461.
14. Eto T., Kinoshita K., Yoshikawa K., Muramatsu M., Honjo T. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells. Proc. Natl. Acad. Sci. USA 2003, 100:12895-12898.
15. Gee P., Ando Y., Kitayama H., Yamamoto S.P., Kanemura Y., Ebina H., Kawaguchi Y., Koyanagi Y. APOBEC1-mediated editing and attenuation of herpes simplex virus 1 DNA indicate that neurons have an antiviral role during herpes simplex encephalitis. J. Virol. 2011, 85:9726-9736.
16. Goldstein J.L., Kita T., Brown M.S. Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolemia. NEJM 1983, 309:288-296.
17. Gonzalez M.C., Suspene R., Henry M., Guetard D., Wain-Hobson S., Vartanian J.P. Human APOBEC1 cytidine deaminase edits HBV DNA. Retrovirology 2009, 6:96.
18. Halemano K., Guo K., Heilman K.J., Barrett B.S., Smith D.S., Hasenkrug K.J., Santiago M.L. Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection. Proc. Natl. Acad. Sci. USA 2014, 111:7759-7764.
19. Harper M.S., Barrett B.S., Smith D.S., Li S.X., Gibbert K., Dittmer U., Hasenkrug K.J., Santiago M.L. IFN-alpha treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3. J. Immunol. 2013, 190:1583-1590.
20. Harris R.S., Petersen-Mahrt S.K., Neuberger M.S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell 2002, 10:1247-1253.
21. Hasenkrug K.J., Chesebro B. Immunity to retroviral infection: the Friend virus model. Proc. Natl. Acad. Sci. USA 1997, 94:7811-7816.
22. He J.Y., Cheng H.J., Wang Y.F., Zhu Y.T., Li G.Q. Development of a real-time quantitative reverse transcriptase PCR assay for detection of the Friend leukemia virus load in murine plasma. J. Virol. Methods 2008, 147:345-350.
23. Hirano K., Young S.G., Farese R.V., Ng J., Sande E., Warburton C., Powell-Braxton L.M., Davidson N.O. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J. Biol. Chem. 1996, 271:9887-9890.
24. Hoatlin M.E., Kozak S.L., Lilly F., Chakraborti A., Kozak C.A., Kabat D. Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene. Proc. Natl. Acad. Sci. USA 1990, 87:9985-9989.
25. Hultquist J.F., Lengyel J.A., Refsland E.W., LaRue R.S., Lackey L., Brown W.L., Harris R.S. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J. Virol. 2011, 85:11220-11234.
26. Ikeda T., Abd El Galil K.H., Tokunaga K., Maeda K., Sata T., Sakaguchi N., Heidmann T., Koito A. Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons. Nucleic Acids Res. 2011, 39:5538-5554.
27. Ikeda T., Ohsugi T., Kimura T., Matsushita S., Maeda Y., Harada S., Koito A. The antiretroviral potency of APOBEC1 deaminase from small animal species. Nucleic Acids Res. 2008, 36:6859-6871.
28. Ishibashi S., Herz J., Maeda N., Goldstein J.L., Brown M.S. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc. Natl. Acad. Sci. USA 1994, 91:4431-4435.
29. Jern P., Stoye J.P., Coffin J.M. Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. PLoS Genet. 2007, 3:2014-2022.
30. Jones P.H., Mehta H.V., Okeoma C.M. A novel role for APOBEC3: Susceptibility to sexual transmission of murine acquired immunodeficiency virus (mAIDS) is aggravated in APOBEC3 deficient mice. Retrovirology 2012, 9:50.
31. Kim E.Y., Lorenzo-Redondo R., Little S.J., Chung Y.S., Phalora P.K., Maljkovic Berry I., Archer J., Penugonda S., Fischer W., Richman D.D., Bhattacharya T., Malim M.H., Wolinsky S.M. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection. PLoS Pathog. 2014, 10:e1004281.
32. Knoepfel S.A., Di Giallonardo F., Daumer M., Thielen A., Metzner K.J. In-depth analysis of G-to-A hypermutation rate in HIV-1 env DNA induced by endogenous APOBEC3 proteins using massively parallel sequencing. J. Virol. Methods 2011, 171:329-338.
33. Kolokithas A., Rosenke K., Malik F., Hendrick D., Swanson L., Santiago M.L., Portis J.L., Hasenkrug K.J., Evans L.H. The glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3. J. Virol. 2010, 84:10933-10936.
34. Krisko J.F., Martinez-Torres F., Foster J.L., Garcia J.V. HIV restriction by APOBEC3 in humanized mice. PLoS Pathog. 2013, 9:e1003242.
35. Land A.M., Law E.K., Carpenter M.A., Lackey L., Brown W.L., Harris R.S. Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic. J. Biol. Chem. 2013, 288:17253-17260.
36. Langlois M.A., Beale R.C., Conticello S.G., Neuberger M.S. Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities. Nucleic Acids Res. 2005, 33:1913-1923.
37. Langlois M.A., Kemmerich K., Rada C., Neuberger M.S. The AKV murine leukemia virus is restricted and hypermutated by mouse APOBEC3. J. Virol. 2009, 83:11550-11559.
38. Li S.X., Barrett B.S., Harper M.S., Heilman K.J., Halemano K., Steele A.K., Guo K., Silverman R.H., Santiago M.L. Ribonuclease L is not critical for innate restriction and adaptive immunity against Friend retrovirus infection. Virology 2013, 443:134-142.
39. Lilly F., Steeves R.A. B-tropic Friend virus: a host-range pseudotype of spleen focus-forming virus (SFFV). Virology 1973, 55:363-370.
40. Low A., Okeoma C.M., Lovsin N., de las Heras M., Taylor T.H., Peterlin B.M., Ross S.R., Fan H. Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene. Virology 2009, 385:455-463.
41. MacMillan A.L., Kohli R.M., Ross S.R. APOBEC3 inhibition of mouse mammary tumor virus infection: the role of cytidine deamination versus inhibition of reverse transcription. J. Virol. 2013, 87:4808-4817.
42. Malim M.H. APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2009, 364:675-687.
43. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003, 424:99-103.
44. Marques R., Antunes I., Eksmond U., Stoye J., Hasenkrug K., Kassiotis G. B lymphocyte activation by coinfection prevents immune control of Friend virus infection. J. Immunol. 2008, 181:3432-3440.
45. Masella A.P., Bartram A.K., Truszkowski J.M., Brown D.G., Neufeld J.D. PANDAseq: paired-end assembler for illumina sequences. BMC Bioinform. 2012, 13:31.
46. Minkah N., Chavez K., Shah P., Maccarthy T., Chen H., Landau N., Krug L.T. Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3. Virology 2014, 454-455:215-226.
47. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
48. Navaratnam N., Morrison J.R., Bhattacharya S., Patel D., Funahashi T., Giannoni F., Teng B.B., Davidson N.O., Scott J. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J. Biol. Chem. 1993, 268:20709-20712.
49. Nishigaki K., Hanson C., Jelacic T., Thompson D., Ruscetti S. Friend spleen focus-forming virus transforms rodent fibroblasts in cooperation with a short form of the receptor tyrosine kinase Stk. Proc. Natl. Acad. Sci. USA 2005, 102:15488-15493.
50. Okeoma C.M., Lovsin N., Peterlin B.M., Ross S.R. APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 2007, 445:927-930.
51. Persons D.A., Paulson R.F., Loyd M.R., Herley M.T., Bodner S.M., Bernstein A., Correll P.H., Ney P.A. Fv2 encodes a truncated form of the Stk receptor tyrosine kinase. Nat. Genet. 1999, 23:159-165.
52. Petersen-Mahrt S.K., Neuberger M.S. In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1). J. Biol. Chem. 2003, 278:19583-19586.
53. Petit V., Guetard D., Renard M., Keriel A., Sitbon M., Wain-Hobson S., Vartanian J.P. Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. J. Mol. Biol. 2009, 385:65-78.
54. Powell-Braxton L., Veniant M., Latvala R.D., Hirano K.I., Won W.B., Ross J., Dybdal N., Zlot C.H., Young S.G., Davidson N.O. A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. Nat. Med. 1998, 4:934-938.
55. Rehwinkel J. Mouse knockout models for HIV-1 restriction factors. Cell. Mol. Life Sci. 2014, 71:3749-3766.
56. Renard M., Henry M., Guetard D., Vartanian J.P., Wain-Hobson S. APOBEC1 and APOBEC3 cytidine deaminases as restriction factors for hepadnaviral genomes in non-humans in vivo. J. Mol. Biol. 2010, 400:323-334.
57. Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., Catalan N., Forveille M., Dufourcq-Labelouse R., Gennery A., Tezcan I., Ersoy F., Kayserili H., Ugazio A.G., Brousse N., Muramatsu M., Notarangelo L.D., Kinoshita K., Honjo T., Fischer A., Durandy A. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000, 102:565-575.
58. Robertson S.J., Ammann C.G., Messer R.J., Carmody A.B., Myers L., Dittmer U., Nair S., Gerlach N., Evans L.H., Cafruny W.A., Hasenkrug K.J. Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus. J. Virol. 2008, 82:408-418.
59. Rohlmann A., Gotthardt M., Hammer R.E., Herz J. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J. Clin. Invest. 1998, 101:689-695.
60. Rosenberg B.R., Hamilton C.E., Mwangi M.M., Dewell S., Papavasiliou F.N. Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3' UTRs. Nat. Struct. Mol. Biol. 2011, 18:230-236.
61. Santiago M.L., Greene W.C. The role of the Apobec3 family of cytidine deaminases in innate immunity, G-to-A hypermutation and evolution of retroviruses. Origin and Evolution of Viruses 2008, 183-206. Academic Press, London, UK. E. Domingo, C.R. Parrish, J.J. Holland (Eds.).
62. Santiago M.L., Montano M., Benitez R., Messer R.J., Yonemoto W., Chesebro B., Hasenkrug K.J., Greene W.C. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science 2008, 321:1343-1346.
63. Santiago M.L., Smith D.S., Barrett B.S., Montano M., Benitez R.L., Pelanda R., Hasenkrug K.J., Greene W.C. Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor. J. Virol. 2011, 85:189-199.
64. Schmitt K., Guo K., Algaier M., Ruiz A., Cheng F., Qiu J., Wissing S., Santiago M.L., Stephens E.B. Differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution. Virology 2011, 419:24-42.
65. Schoggins J.W., Wilson S.J., Panis M., Murphy M.Y., Jones C.T., Bieniasz P., Rice C.M. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011, 472:481-485.
66. Shay T., Kang J. Immunological Genome Project and systems immunology. Trends Immunol. 2013, 34:602-609.
67. Smith D.S., Guo K., Barrett B.S., Heilman K.J., Evans L.H., Hasenkrug K.J., Greene W.C., Santiago M.L. Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. PLoS Pathog. 2011, 7:e1002284.
68. Sowden M., Hamm J.K., Smith H.C. Overexpression of APOBEC-1 results in mooring sequence-dependent promiscuous RNA editing. J. Biol. Chem. 1996, 271:3011-3017.
69. Suspene R., Aynaud M.M., Koch S., Pasdeloup D., Labetoulle M., Gaertner B., Vartanian J.P., Meyerhans A., Wain-Hobson S. Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo. J. Virol. 2011, 85:7594-7602.
70. Takeda E., Tsuji-Kawahara S., Sakamoto M., Langlois M.A., Neuberger M.S., Rada C., Miyazawa M. Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. J. Virol. 2008, 82:10998-11008.
71. Teng B., Burant C.F., Davidson N.O. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 1993, 60:1816-1819.
72. Tsuji-Kawahara S., Chikaishi T., Takeda E., Kato M., Kinoshita S., Kajiwara E., Takamura S., Miyazawa M. Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice. J. Virol. 2010, 84:6082-6095.
73. Vartanian J.P., Guetard D., Henry M., Wain-Hobson S. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 2008, 320:230-233.
74. Wedekind J.E., Dance G.S., Sowden M.P., Smith H.C. Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business. Trends Genet. 2003, 19:207-216.
75. Yamanaka S., Balestra M.E., Ferrell L.D., Fan J., Arnold K.S., Taylor S., Taylor J.M., Innerarity T.L. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. USA 1995, 92:8483-8487.
76. Yang Y., Sowden M.P., Smith H.C. Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1. J. Biol. Chem. 2000, 275:22663-22669.
77. Yu Q., Konig R., Pillai S., Chiles K., Kearney M., Palmer S., Richman D., Coffin J.M., Landau N.R. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat. Struct. Mol. Biol. 2004, 11:435-442.